Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Cosmoprof WW BolognaCosmoprof WW Bologna
Not Confirmed
Not Confirmed
26-29 March, 2026
Asia Pharma ExpoAsia Pharma Expo
Not Confirmed
Not Confirmed
29-31 March, 2026
Bio-Europe SpringBio-Europe Spring
Not Confirmed
Not Confirmed
31 March-01 April, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Cosmoprof WW BolognaCosmoprof WW Bologna
Industry Trade Show
Not Confirmed
26-29 March, 2026
Asia Pharma ExpoAsia Pharma Expo
Industry Trade Show
Not Confirmed
29-31 March, 2026
Bio-Europe SpringBio-Europe Spring
Industry Trade Show
Not Confirmed
31 March-01 April, 2026
Digital content

20 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/20/3259673/0/en/Milestone-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Update-on-the-Commercial-Launch-of-CARDAMYST-etripamil-Nasal-Spray-for-the-Treatm.html

16 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/16/3256248/0/en/Milestone-Pharmaceuticals-to-Present-Data-on-CARDAMYST-etripamil-Nasal-Spray-at-the-2026-American-College-of-Cardiology-Annual-Scientific-Session.html

12 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/12/3254570/0/en/Milestone-Pharmaceuticals-to-Announce-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-March-20-2026.html

10 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/10/3235242/0/en/Milestone-Pharmaceuticals-Appoints-David-Sandoval-as-General-Counsel-and-Chief-Compliance-Officer.html

03 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/03/3230988/0/en/Milestone-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

26 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/26/3225590/0/en/Milestone-Pharmaceuticals-Announces-U-S-Availability-of-CARDAMYST-etripamil-Nasal-Spray-the-First-and-Only-FDA-Approved-Self-Administered-Treatment-for-Adults-with-Paroxysmal-Supra.html
ABOUT THIS PAGE